Royal Bank of Canada’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-5,870
| Closed | -$105K | – | 6440 |
|
|
2018
Q3 | $105K | Sell |
5,870
-1,180
| -17% | -$21.1K | ﹤0.01% | 4240 |
|
|
2018
Q2 | $97K | Hold |
7,050
| – | – | ﹤0.01% | 4249 |
|
|
2018
Q1 | $65K | Sell |
7,050
-5,832
| -45% | -$53.8K | ﹤0.01% | 4329 |
|
|
2017
Q4 | $55K | Sell |
12,882
-5,728
| -31% | -$24.5K | ﹤0.01% | 4404 |
|
|
2017
Q3 | $27K | Sell |
18,610
-79,530
| -81% | -$115K | ﹤0.01% | 5058 |
|
|
2017
Q2 | $147K | Sell |
98,140
-24,821
| -20% | -$37.2K | ﹤0.01% | 3855 |
|
|
2017
Q1 | $316K | Sell |
122,961
-12,885
| -9% | -$33.1K | ﹤0.01% | 3413 |
|
|
2016
Q4 | $346K | Sell |
135,846
-6,300
| -4% | -$16K | ﹤0.01% | 3379 |
|
|
2016
Q3 | $440K | Sell |
142,146
-9,019
| -6% | -$27.9K | ﹤0.01% | 3145 |
|
|
2016
Q2 | $486K | Sell |
151,165
-47
| -0% | -$151 | ﹤0.01% | 3098 |
|
|
2016
Q1 | $469K | Sell |
151,212
-10,719
| -7% | -$33.2K | ﹤0.01% | 3109 |
|
|
2015
Q4 | $650K | Sell |
161,931
-27,891
| -15% | -$112K | ﹤0.01% | 2898 |
|
|
2015
Q3 | $869K | Sell |
189,822
-2,824
| -1% | -$12.9K | ﹤0.01% | 2506 |
|
|
2015
Q2 | $1M | Buy |
192,646
+111,702
| +138% | +$580K | ﹤0.01% | 2506 |
|
|
2015
Q1 | $507K | Sell |
80,944
-9,493
| -10% | -$59.5K | ﹤0.01% | 3062 |
|
|
2014
Q4 | $569K | Sell |
90,437
-965
| -1% | -$6.07K | ﹤0.01% | 2916 |
|
|
2014
Q3 | $556K | Buy |
91,402
+1,085
| +1% | +$6.6K | ﹤0.01% | 2870 |
|
|
2014
Q2 | $595K | Sell |
90,317
-11,568
| -11% | -$76.2K | ﹤0.01% | 2818 |
|
|
2014
Q1 | $2.43M | Buy |
101,885
+21,459
| +27% | +$511K | ﹤0.01% | 1771 |
|
|
2013
Q4 | $859K | Buy |
80,426
+34,166
| +74% | +$365K | ﹤0.01% | 2452 |
|
|
2013
Q3 | $616K | Buy |
46,260
+5,188
| +13% | +$69.1K | ﹤0.01% | 2722 |
|
|
2013
Q2 | $539K | Buy |
+41,072
| New | +$539K | ﹤0.01% | 2592 |
|